HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,893,898 | +190.7% | 887,274 | +174.5% | 0.06% | +215.8% |
| Q2 2023 | $11,660,900 | +25.8% | 323,285 | +33.2% | 0.02% | +26.7% |
| Q1 2023 | $9,268,827 | -59.1% | 242,703 | -39.1% | 0.02% | -61.5% |
| Q4 2022 | $22,658,490 | -22.9% | 398,216 | -46.5% | 0.04% | -25.0% |
| Q3 2022 | $29,405,000 | +6.8% | 743,687 | +18.8% | 0.05% | +13.0% |
| Q2 2022 | $27,545,000 | -1.2% | 626,042 | -10.4% | 0.05% | +31.4% |
| Q1 2022 | $27,872,000 | -22.1% | 698,904 | -21.5% | 0.04% | -12.5% |
| Q4 2021 | $35,784,000 | – | 889,937 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |